|We Bring Powerful Leverage to Your Success as an Active Partner||We Raised USD 200M from Entrepreneurs, Business Leaders and Family Offices||We Invest Early Stage and Support Companies All Along their Growth|
July 18th, 2016 - Zimmer Biomet ($ZBH, NYSE) announces the acquisition of Medtech SA ($ROSA, Euronext) for €50 per share, a 62% premium on last quote.
Newfund sold its stake that represented 22% of pre-diluted capital. A public offer will follow on the remaining shares.
The transaction is a recognition for Medtech SA’s robotic solutions. The company is a world leader for brain robotic surgery, opening the way to epilepsy treatment by electrodes and to deep brain simulation (DBS) for diseases such as Parkinson and other neurological pathologies.
Newfund was Medtech SA’s first institutional investor and has supported the company all along since 2010. We thank Medtech SA’s founder and CEO Bertin Nahum and his team for this outstanding journey.
Is Google spiking? Now, you don't have to watch the market all day to find out: A new app called Trigger can alert you to moves you care about.